5 Dec 2007

Neupro® Filed in Europe for the Treatment of Restless Legs Syndrome

Read More
3 Dec 2007

UCB Announces Positive Phase III Trial Results for Keppra XR(TM)

Read More
29 Nov 2007

UCB Announces FDA Filing for lacosamide in the Treatment of Partial Onset Seizures in Adults with Epilepsy

Read More
29 Nov 2007

UCB Announces FDA Filing for lacosamide in the Treatment of Diabetic Neuropathic Pain

Read More
16 Nov 2007

UCB to Appeal European Negative Opinion on CIMZIA® for the Treatment of Patients with Crohn's Disease

Read More
26 Oct 2007

UCB Announces Initiation of Phase III Clinical Program for RikeltaTM (brivaracetam) as Adjunctive Treatment in Partial-Onset Epilepsy

Read More
10 Oct 2007

UCB celebrates the Grand opening of a new facility in Shannon in presence of H.M. King Albert II, and appeals to build on Belgian strong innovative capacities

Read More
4 Oct 2007

UCB's Keppra® patent litigation in the US settled

Read More
2 Oct 2007

New prescription allergy treatment XYZAL® (levocetirizine dihydrochloride) now available for fall allergy season in the USA

Read More
17 Aug 2007

UCB Announces Submission of Lacosamide Marketing Application for Diabetic Neuropathic Pain

Read More
Subscribe to